Mechanical thrombectomy is a catheter-based procedure that physically removes a blood clot from an artery in the brain during an acute ischemic stroke, and it stands as the single most effective treatment for strokes caused by large vessel occlusions. A meta-analysis of randomized trials found that patients who received thrombectomy were about 45% more likely to achieve functional independence at 90 days compared with standard medical care alone.1PubMed. Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta-Analysis of Randomized Trials The procedure’s rise from an experimental technique plagued by disappointing trial results to the gold standard of acute stroke care is one of the most dramatic turnarounds in modern neurology, and its reach is still expanding into new patient populations, new blood vessel territories, and even organs beyond the brain.
What the Procedure Actually Involves
A neurointerventionalist threads a catheter from an artery in the groin (or sometimes the wrist) up through the body’s arterial system and into the blocked brain artery. Once the catheter tip reaches the clot, there are two main ways to remove it. The first uses a stent retriever, a small wire-mesh device that expands inside the clot, traps it, and is then pulled back out along with the clot in tow. The second uses aspiration, essentially a powerful vacuum applied through the catheter tip to suck the clot out. Both approaches achieve roughly the same final success rates for reopening the artery, around 83–84%, and both produce similar rates of functional independence at 90 days.2PubMed Central. Outcomes of Stent Retriever versus Aspiration-First Thrombectomy in Ischemic Stroke: A Systematic Review and Meta-Analysis The differences are in the details: stent retrievers tend to achieve successful blood flow on the first pass more often and require fewer backup devices, while aspiration is typically about seven minutes faster from catheter insertion to restored blood flow.
In practice, many operators use a combined approach, deploying a stent retriever while simultaneously applying aspiration. The choice can also depend on where the clot is sitting. For blockages at the terminal internal carotid artery, one study found aspiration achieved higher rates of the most complete reopening grades and cut procedure times roughly in half compared with stent retrievers at that particular location.3American Journal of Neuroradiology. Comparison of Aspiration versus Stent Retriever Thrombectomy as the Preferred Strategy for Patients with Acute Terminal Internal Carotid Artery Occlusion
How the Evidence Was Built
The path to widespread acceptance was not straightforward. Early randomized trials in 2013 using first-generation devices found no benefit from thrombectomy over clot-dissolving drugs alone. Those trials were limited by older technology, loose patient selection criteria, and significant treatment delays.4Journal of Korean Neurosurgical Society. Endovascular Stroke Therapy Focused on Stent Retriever Thrombectomy and Direct Clot Aspiration: Historical Review and Modern Application Then in 2015, five landmark trials using newer stent-retriever devices and advanced brain imaging to select patients all produced overwhelmingly positive results. These studies, including MR CLEAN, ESCAPE, EXTEND IA, SWIFT PRIME, and REVASCAT, cemented thrombectomy as the standard of care for large vessel occlusion strokes.5PubMed Central. Mechanical Thrombectomy Is Now the Gold Standard for Acute Ischemic Stroke: Implications for Routine Clinical Practice
The key lesson from the failed early trials was that patient selection and speed matter enormously. The successful 2015 trials used brain imaging to confirm a large clot was present and that enough salvageable brain tissue still existed before committing to the procedure. They also minimized workflow delays, getting patients into the procedure suite faster.
Why Time and Brain Tissue Matter
When a major brain artery is blocked, there is a core of tissue that dies quickly and a surrounding zone of at-risk but still viable tissue called the penumbra. Thrombectomy works by restoring blood flow fast enough to rescue that penumbra before it joins the dead core. When operators achieve excellent reopening of the artery, about 81% of the at-risk brain tissue can be saved. When reopening is incomplete, that number drops to around 39%.6American Journal of Neuroradiology. Fate of the Penumbra after Mechanical Thrombectomy
Despite early and successful reopening of the artery in over 80% of treated patients, roughly half of those who undergo thrombectomy still do not achieve functional independence. The most common reason is that the core of irreversibly damaged tissue was already too large by the time blood flow was restored.7Nature Reviews Neurology. Protecting the ischaemic penumbra as an adjunct to thrombectomy for acute stroke This is why imaging-based patient selection has become so central. The goal is to identify people who still have significant salvageable tissue, regardless of how many hours have passed since the stroke began.
Thrombectomy was initially approved within a window of about six to eight hours from symptom onset. Later trials extended the therapeutic window to 24 hours for patients whose imaging shows a favorable mismatch between their small core and large penumbra.8PubMed Central. Four Decades of Ischemic Penumbra and Its Implication for Ischemic Stroke In the extended window, outcomes appear similar whether patients are selected using advanced perfusion imaging or simpler CT-based imaging, suggesting that access to the most sophisticated scanners should not be a barrier to treatment.9PubMed. Stroke Imaging Selection Modality and Endovascular Therapy Outcomes in the Early and Extended Time Windows
Getting Patients to the Right Hospital
Thrombectomy requires a specialized team and equipment that only exist at certain hospitals, often called comprehensive stroke centers. This creates a logistics problem: should paramedics drive a suspected stroke patient directly to the nearest thrombectomy-capable center, even if it is farther away (the “mothership” model), or should they go to the nearest hospital for initial evaluation and clot-dissolving medication, then transfer the patient if needed (the “drip-and-ship” model)?
Meta-analyses have found that the mothership approach generally produces better 90-day outcomes, with higher rates of functional independence (about 53% versus 47%) and shorter times from symptom onset to the start of the procedure.10PubMed Central. Mothership versus Drip-and-Ship Model for Mechanical Thrombectomy in Acute Stroke: A Systematic Review and Meta-Analysis for Clinical and Radiological Outcomes The drip-and-ship model has also been linked to higher rates of symptomatic brain bleeding, likely because of the longer overall delays.11PubMed. Comparison of mothership versus drip-and-ship models in treating patients with acute ischemic stroke: A systematic review and meta-analysis That said, for patients who live far from a thrombectomy center, the drip-and-ship model remains essential. When procedures are optimized and delays kept minimal, some single-center studies have found comparable outcomes between the two approaches.12Journal of Stroke and Cerebrovascular Diseases. Drip and ship and mothership models of mechanical thrombectomy result in similar outcomes in acute ischemic stroke of the anterior circulation The real enemy is wasted time, not which model is used.
Should Patients Be Given Clot-Dissolving Drugs First?
A longstanding question has been whether giving intravenous clot-dissolving medication (IV thrombolysis) before thrombectomy, known as bridging therapy, adds any benefit compared with going straight to the catheter procedure. A meta-analysis found no significant difference in 90-day functional independence or mortality between the two strategies, though bridging therapy was associated with slightly higher rates of successful reopening but also more symptomatic brain bleeding.13PubMed Central. Direct Mechanical Thrombectomy Versus Prior Bridging Intravenous Thrombolysis in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
The picture is not entirely settled, though. An analysis from the SELECT cohort found that bridging therapy was associated with roughly double the odds of functional independence and substantially lower mortality compared with direct thrombectomy.14PubMed Central. Clinical and Neuroimaging Outcomes of Direct Thrombectomy vs Bridging Therapy in Large Vessel Occlusion Current guidelines generally recommend giving IV thrombolysis when eligible, without delaying the trip to the thrombectomy suite. For patients who present directly to a thrombectomy-capable center where the procedure can begin quickly, the added benefit of first administering thrombolysis remains an active area of debate.
Risks and Complications
Thrombectomy carries real risks. In a large registry analysis, the overall complication rate was about 20 per 100 patients treated.15PubMed. Complications of mechanical thrombectomy for acute ischemic stroke: Incidence, risk factors, and clinical relevance in the Italian Registry of Endovascular Treatment in acute stroke A Japanese study found periprocedural complications in about 14% of patients, with the most common being injury to small perforating arteries and vessel perforation.16PubMed Central. The Analysis of Periprocedural Complications in Mechanical Thrombectomy for Acute Occlusion of the Intracranial Artery The two strongest predictors of complications are atrial fibrillation and longer procedure times.
Symptomatic intracranial hemorrhage, the most feared complication, is more likely when the initial stroke damage is already extensive, when there are long delays from symptom onset to groin puncture, and when the operator needs more than three passes of the retrieval device.17PubMed Central. Predictors of intracranial hemorrhage after mechanical thrombectomy using a stent-retriever for anterior circulation ischemic stroke Diabetes, higher stroke severity at presentation, and certain clot locations (particularly the carotid terminus and M2 branch of the middle cerebral artery) also increase the risk of bleeding and arterial perforation.18PubMed. Complications of mechanical thrombectomy for acute ischemic stroke: Incidence, risk factors, and clinical relevance in the Italian Registry of Endovascular Treatment in acute stroke Both symptomatic brain bleeding and arterial perforation significantly worsen functional outcomes and survival at three months.
The Anesthesia Question
Whether to perform thrombectomy under general anesthesia or conscious sedation has been debated for years. General anesthesia keeps the patient completely still, which can make the procedure technically easier, but it takes time to set up and historically was associated with worse outcomes, likely due to delays and blood pressure drops. Conscious sedation allows faster starts and ongoing neurological monitoring but risks patient movement during a delicate procedure.
Recent randomized evidence is shifting the balance. The SEGA trial found an 81% probability that general anesthesia was superior to sedation for 90-day outcomes, along with higher reperfusion rates.19JAMA Neurology. Sedation vs General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke: The SEGA Randomized Clinical Trial A meta-analysis similarly found significantly higher successful reopening rates with general anesthesia, though no significant difference in 90-day functional recovery, mortality, or pneumonia.20PubMed Central. General anesthesia versus conscious sedation in mechanical thrombectomy for patients with acute ischemic stroke: systematic review and meta-analysis There is nuance, however: among patients with milder strokes, conscious sedation was associated with nearly double the odds of excellent functional outcomes despite lower rates of complete reopening.21PubMed Central. General Anesthesia Versus Conscious Sedation in Thrombectomy Patients With Low NIHSS Anterior Circulation Stroke The emerging consensus is that general anesthesia may be preferred in many cases, but clinicians need to weigh each patient’s severity and institutional readiness.
How Completely the Artery Needs to Be Reopened
Operators grade how well they have restored blood flow using a scoring system. For years, the benchmark for “successful” was a grade of 2b or better on this scale, meaning most of the downstream territory was reperfused. But finer-grained analysis shows that outcomes keep improving beyond that threshold. A study comparing grades found that the probability of a good outcome was 17% for the lower end of 2b, rose to 54% at grade 2c, and climbed further at the highest grade of 3.22PubMed Central. Validation of the extended thrombolysis in cerebral infarction score in a real world cohort The push now is toward near-complete or complete reperfusion as the procedural target, since even partial residual blockage measurably worsens the chance of recovery.23PubMed. 2B, 2C, or 3: What Should Be the Angiographic Target for Endovascular Treatment in Ischemic Stroke?
Expanding Frontiers: Strokes With Large Areas of Damage
Thrombectomy was originally reserved for patients with a relatively small core of already-dead brain tissue. Patients with large cores were excluded from early trials under the assumption that the damage was already done. More recent evidence has challenged that assumption. The SELECT2 trial, which enrolled patients with large infarct cores, found that 20% of thrombectomy patients achieved functional independence versus only 7% with medical care alone, a nearly threefold relative improvement.24PubMed. Trial of Endovascular Thrombectomy for Large Ischemic Strokes
The benefit does taper as the core grows larger. Among patients with moderate-to-large cores (roughly 50–80 mL of damaged tissue), about a quarter achieved good outcomes, though mortality was about 35%.25PubMed. Acute Stroke With Large Ischemic Core Treated by Thrombectomy One study estimated that the benefit of thrombectomy over medical care largely disappeared when core volumes exceeded around 120–130 mL.26Journal of NeuroInterventional Surgery. Identifying large ischemic core volume ranges in acute stroke that can benefit from mechanical thrombectomy This is not a hard cutoff, as younger patients and those with good collateral blood flow may still benefit at larger volumes. But it gives clinicians a rough boundary for shared decision-making with families.
Strokes in the Back of the Brain
Most thrombectomy evidence involves the anterior circulation, the large arteries feeding the front and sides of the brain. Strokes caused by blockage of the basilar artery, which supplies the brainstem and back of the brain, are particularly devastating, but randomized trials specifically testing thrombectomy here initially came up empty. The BEST and BASICS trials both failed to show a significant benefit for thrombectomy in basilar artery occlusion within standard time windows.27PubMed Central. Endovascular Thrombectomy for Acute Basilar Artery Occlusion: Latest Findings and Critical Thinking on Future Study Design
However, in the sickest patients, those with severe symptoms, a different picture emerges. An analysis of patients with severe basilar occlusion strokes found that thrombectomy was associated with more than triple the odds of a favorable functional outcome and a sharp reduction in mortality compared with medical treatment alone.28JAMA Network Open. Outcomes of Endovascular Therapy in Acute Basilar Artery Occlusion With Severe Symptoms The technical success rate for thrombectomy appears to be actually higher in the basilar artery than in the anterior circulation, possibly because the anatomy allows easier catheter access.29Journal of NeuroInterventional Surgery. Mechanical thrombectomy for basilar artery occlusion: efficacy, outcomes, and futile recanalization in comparison with the anterior circulation The ongoing challenge is identifying which basilar occlusion patients will benefit, since many arrive with severe brainstem damage already done.
The Push Into Smaller Arteries
Medium vessel occlusions, affecting arteries like the M2 or M3 branches of the middle cerebral artery, represent the next frontier. These strokes can still cause significant disability, but the smaller artery diameter raises safety concerns. A meta-analysis of over 7,000 patients found no significant difference in functional independence or mortality between thrombectomy and standard medical treatment for medium and distal vessel blockages. Thrombectomy did, however, come with a meaningfully higher rate of bleeding complications, including a roughly sevenfold increase in subarachnoid hemorrhage.30PubMed. Endovascular thrombectomy for acute ischemic stroke due to medium or distal vessel occlusion: A systematic review and meta-analysis Vessel perforation is a particular concern in these smaller branches, occurring in about 5% of cases and associated with dramatically worse outcomes when it happens.31PubMed. Incidence and clinical outcomes of perforations during mechanical thrombectomy for medium vessel occlusion in acute ischemic stroke This area is still evolving, with newer, smaller devices being developed specifically for these smaller arteries.
Tandem Lesions and Complex Anatomy
Some patients have a “tandem” pattern: a blockage in a brain artery plus a second narrowing or blockage in the carotid artery in the neck, often due to atherosclerosis or dissection. These cases are technically more challenging and were largely excluded from the pivotal trials. The standard approach now involves treating both problems during the same procedure, most commonly by placing a stent in the neck artery while also removing the clot from the brain artery.32PubMed Central. Diagnosis and management of tandem occlusion in acute ischemic stroke
The multicenter CERES-TANDEM study found that emergent carotid stenting improved 90-day functional outcomes without a significant increase in brain bleeding.33PubMed. Emergent Carotid Stenting for Acute Anterior Circulation Ischemic Stroke With Tandem Lesions: The Multicenter CERES-TANDEM Study For the specific subgroup where the neck artery blockage is caused by a dissection (a tear in the artery wall) rather than atherosclerosis, emergent stenting improved the rate of successful brain artery reopening but did not significantly change functional independence rates.34PubMed. Emergent Carotid Stenting During Thrombectomy in Tandem Occlusions Secondary to Dissection Treatment decisions in tandem cases often have to be made on the fly based on what the operator finds during the procedure.
What the Clot Is Made of Matters
One underappreciated factor in thrombectomy success is the composition of the clot itself. Clots rich in red blood cells tend to be softer and easier to grab or suction out, while clots with more fibrin and white blood cells are tougher and more resistant to retrieval. In one study, clots that were successfully removed on the first pass had a mean red blood cell content of about 17%, while clots requiring multiple passes averaged 27%, a counterintuitive finding suggesting that the fibrin-rich, low-red-cell clots were actually the cooperative ones for certain devices.35PubMed Central. Impact of histological clot composition on preprocedure imaging and mechanical thrombectomy Higher white blood cell content in the thrombus has been linked to longer procedure times and worse reopening outcomes.36PubMed. The Impact of Histological Clot Composition in Embolic Stroke In laboratory models, fibrin-rich clots have shown significantly lower recanalization rates with mechanical retrieval compared with red-cell-rich clots.37American Journal of Neuroradiology. The Impact of Thromboemboli Histology on the Performance of a Mechanical Thrombectomy Device
This research is more than academic. Clot composition can sometimes be inferred from imaging characteristics before the procedure begins, and it may eventually guide device selection or combination strategies. Clots from cardiac sources like atrial fibrillation, for instance, tend to differ in composition from those caused by large-artery atherosclerosis.
Blood Pressure After the Procedure
Managing blood pressure after successful thrombectomy has turned out to be trickier than expected. The intuitive approach would be to aggressively lower blood pressure to protect fragile, freshly reperfused brain tissue from bleeding. But the largest randomized trial testing this, ENCHANTED2, was actually stopped early due to harm in the intensive blood-pressure-lowering group (targeting systolic pressure below 120 mm Hg).38PubMed. Intensive Blood Pressure Control After Mechanical Thrombectomy for Acute Ischemic Stroke The emerging view is that the brain’s ability to regulate its own blood flow is compromised after a stroke, and pushing blood pressure too low may starve vulnerable tissue of the blood flow it needs to recover. The ideal target remains unclear, and current practice favors a moderate approach rather than aggressive lowering.39PubMed Central. Blood pressure management after endovascular thrombectomy: Insights of recent randomized controlled trials
AI Is Changing How Quickly Patients Get Treated
Artificial intelligence is being integrated into the stroke care chain in ways that are already measurable. AI software can automatically detect large vessel occlusions on CT scans, score the extent of early stroke damage, and immediately alert the stroke team, often shaving critical minutes off the notification process.40PubMed Central. The Role of Artificial Intelligence in Acute Ischemic Stroke Care: A Narrative Review
A national study across England found that hospitals using AI stroke imaging software doubled their thrombectomy rate, from about 2.3% of stroke patients treated to 4.6%, a substantially larger increase than at hospitals without the software.41The Lancet Digital Health. Real-world impact of artificial intelligence stroke imaging software on endovascular thrombectomy and clinical outcomes in England In a large US hospital network, spokes equipped with AI-driven triage had door-in-door-out times about 40 minutes shorter than non-AI spokes and meaningfully faster decision-to-puncture times.42Journal of Neurology, Neurosurgery & Psychiatry. Impact of an artificial intelligence–driven triage system on workflow and transfer efficiency The effect is not just about speed; more patients are being identified as thrombectomy candidates in the first place, patients who might previously have been missed during busy emergency department shifts.
Thrombectomy in Children
Pediatric stroke is rare, which means randomized trial evidence does not exist for children. What we have comes from retrospective case series and meta-analyses of those series. The results are encouraging: a recent meta-analysis reported favorable functional outcomes in about 79% of children treated with thrombectomy, with a mortality rate of roughly 4% and symptomatic brain bleeding in about 1–2%.43PubMed. Mechanical thrombectomy versus medical management for pediatric ischemic stroke: a systematic review and meta-analysis of comparative studies Earlier meta-analyses have echoed the finding of consistently high efficacy and low complication rates.44PubMed. Mechanical Thrombectomy for Pediatric Large Vessel Occlusions: A Systematic Review and Meta-analysis The practical challenge is that adult-sized devices may not fit children’s smaller arteries, and the causes of pediatric stroke (cardiac disease, sickle cell, arterial dissection) differ from those in adults. Prospective studies are still needed, but the existing data supports treating children with large vessel occlusions using thrombectomy when the situation warrants it.
Beyond Stroke: Pulling Clots From the Lungs
The same principle of physically removing a blood clot has been adapted for massive pulmonary embolism, where a large clot blocks the arteries supplying the lungs. In a US cohort of 63 high-risk pulmonary embolism patients treated with a catheter-based thrombectomy device, there were no procedure-related deaths and no major adverse events at 48 hours. Mean pulmonary artery pressure dropped by about 23% immediately after the procedure.45Journal of the Society for Cardiovascular Angiography & Interventions. Mechanical Thrombectomy for High-Risk Pulmonary Embolism: Insights From the US Cohort of the FLASH Registry The appeal is the same as in stroke: rapid physical clot removal provides immediate hemodynamic improvement in the most critical hours.46PubMed. Mechanical thrombectomy for early treatment of massive pulmonary embolism
The Global Access Gap
Despite the strong evidence, most stroke patients worldwide do not have access to thrombectomy. A global assessment found that the median national thrombectomy access rate was under 3% of eligible patients, with a 460-fold disparity between the highest and lowest access regions. Low-income countries had 88% lower access compared with high-income countries. Globally, the availability of trained operators stood at just 16.5% of what would be needed, and thrombectomy-capable centers were at about 21% of optimal.47PubMed. Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study Having a prehospital bypass protocol that routes suspected stroke patients directly to capable centers was associated with a fourfold increase in the odds of adequate access. Closing this gap is arguably the single largest opportunity to reduce stroke-related death and disability worldwide, far outweighing the incremental gains from refining technique or expanding time windows in well-resourced settings.